Health Sciences Clinical Instructor, Anesthesiology, UCSF School of Medicine

General Surgery

Dr. Zindaba L. Kumwenda is an expert in the field of General Surgery. She graduated from Meharry Medical College. Zindaba Kumwenda is a published doctor and has 7 publications published. The lastest was: 'Recurrent pyogenic cholangitis.'

Publications

---

• Chylomicron-bound endotoxin selectively inhibits NF-kappaB activation in rat hepatocytes.
• Triglyceride-rich lipoproteins prevent septic death in rats.
• The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity.
• Extracellular matrix regulates the hepatocellular heat shock response.
• Recurrent pyogenic cholangitis.
• Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats.

Schools

---

• Meharry Medical College School Of Medicine

• Ucsf Medical Center

Doctors Specialties

---

• Critical Care Surgery
• General Surgery

Accepted Insurances

---

Education

---

• UCSF
• UCSF Medical Center
• Meharry Medical College

Hospital

---

• California Pacific Medical Center
• UCSF Medical Center

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1235271396
Last Name Of The Provider	KUMWENDA
First Name Of The Provider	ZINDABA
View All

Similar Doctors

---

	Dr. Jasleen Kukreja, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Linda M. Reilly, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Rochelle A. Dicker, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mitchell J. Cohen, MD This Doctor is OpenDoctor Recommended.
	Dr. Pablo Leon, MD
	Dr. Chris E. Freise, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Michael R. Harrison, MD This Doctor is OpenDoctor Recommended.
	Dr. Amar Nijagal, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Alexander Rabinovich, DDS
	Dr. Frank E. Primus II, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog